John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Kimberly-Clark
KMB
$36.4B
| $58M | 0.17% |
471,166
-128,161
| -21% | -$16.9M |
|
|
152
Coca-Cola
KO
$392B
| $57.9M | 0.17% |
933,104
-3,696,882
| -80% | -$225M |
|
|
SJR
153
DELISTED
Shaw Communications Inc.
SJR
| $57.7M | 0.17% |
1,858,767
-5,406
| -0.3% | -$162K |
|
|
VRN
154
DELISTED
Veren
VRN
| $57.5M | 0.17% |
7,937,399
+2,939,600
| +59% | +$19.8M |
|
155
State Street Energy Select Sector SPDR ETF
XLE
$41.7B
| $56.9M | 0.17% |
1,489,266
-61,978
| -4% | -$2.15M |
|
156
Fortune Brands Innovations
FBIN
$5.32B
| $56.7M | 0.17% |
893,648
+419,271
| +88% | +$32.2M |
|
157
Cleveland-Cliffs
CLF
$6.43B
| $56.7M | 0.17% |
+1,759,078
| New | +$40.1M |
|
158
RH
RH
$2.9B
| $56.4M | 0.17% |
+172,976
| New | +$69.2M |
|
159
Natera
NTRA
$47.9B
| $56.3M | 0.17% |
1,383,682
+1,349,378
| +3,934% | +$81.1M |
|
160
InMode
INMD
$867M
| $56.3M | 0.17% |
1,524,761
+659,531
| +76% | +$29.5M |
|
161
Intuit
INTU
$100B
| $56.2M | 0.17% |
116,928
-84,362
| -42% | -$43.2M |
|
162
Dentsply Sirona
XRAY
$2.18B
| $56M | 0.17% |
+1,138,746
| New | +$60.2M |
|
163
Box
BOX
$4.56B
| $55.6M | 0.16% |
1,913,297
+238,654
| +14% | +$6.28M |
|
164
Eastman Chemical
EMN
$8.47B
| $55.3M | 0.16% |
493,336
+129,849
| +36% | +$15.2M |
|
|
APTV.PRA
165
DELISTED
Aptiv PLC 5.50% Series A Mandatory Convertible Preferred Shares
APTV.PRA
| $54.6M | 0.16% |
400,000
+355,000
| +789% | +$53.5M |
|
166
B2Gold
BTG
$7.29B
| $54M | 0.16% |
11,766,224
+2,534,709
| +27% | +$10.2M |
|
167
Macy's
M
$6B
| $53.5M | 0.16% |
2,196,648
-738,069
| -25% | -$18.9M |
|
|
GRMN
168
Garmin
GRMN
$56.9B
| $53.4M | 0.16% |
450,246
+165,579
| +58% | +$19.9M |
|
169
CGI
GIB
$15.5B
| $53.3M | 0.16% |
668,035
+104,968
| +19% | +$8.73M |
|
170
United Parks & Resorts
PRKS
$2.06B
| $53.3M | 0.16% |
715,952
-443,010
| -38% | -$29.1M |
|
|
MIME
171
DELISTED
Mimecast Limited
MIME
| $53.3M | 0.16% |
669,400
+45,851
| +7% | +$3.65M |
|
172
PBF Energy
PBF
$8.72B
| $53.3M | 0.16% |
2,185,069
-216,286
| -9% | -$4.09M |
|
173
Camden Property Trust
CPT
$10.8B
| $53.1M | 0.16% |
+319,475
| New | +$52.7M |
|
174
Norwegian Cruise Line
NCLH
$7.92B
| $51.2M | 0.15% |
+2,337,891
| New | +$47.8M |
|
175
iShares MSCI USA Min Vol Factor ETF
USMV
$24.4B
| $51.1M | 0.15% |
658,500
-747,600
| -53% | -$56.6M |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.